phenethyl isothiocyanate has been researched along with Cell Transformation, Neoplastic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bones, AM; Chen, D; Zhao, CM; Øverby, A | 1 |
Abdull Razis, AF; Ioannides, C; Konsue, N | 1 |
Ioannides, C; Konsue, N | 1 |
Bliss, RL; Hecht, SS; Kenney, PM; McIntee, EJ; Upadhyaya, P; Wang, M | 1 |
Achanta, G; Arlinghaus, RB; Chen, Z; Chiao, PJ; Demizu, Y; Huang, P; Liu, J; Pelicano, H; Trachootham, D; Zhang, H; Zhou, Y | 1 |
Hua, X; Wu, XJ | 1 |
Futakuchi, M; Hirose, M; Miki, T; Ozaki, M; Shirai, T; Tanaka, H | 1 |
Affatato, A; Barillari, J; Broccoli, M; Iori, R; Paolini, M; Perocco, P; Sapone, A | 1 |
2 review(s) available for phenethyl isothiocyanate and Cell Transformation, Neoplastic
Article | Year |
---|---|
A principal mechanism for the cancer chemopreventive activity of phenethyl isothiocyanate is modulation of carcinogen metabolism.
Topics: Activation, Metabolic; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Cytochrome P-450 Enzyme System; DNA Damage; Humans; Isothiocyanates; Metabolic Detoxication, Phase II; Neoplasms; Protective Factors; Risk Factors | 2015 |
Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Brassicaceae; Cell Transformation, Neoplastic; Fusion Proteins, bcr-abl; Humans; Isothiocyanates; Neoplasms; Oncogene Protein p21(ras); Reactive Oxygen Species | 2007 |
6 other study(ies) available for phenethyl isothiocyanate and Cell Transformation, Neoplastic
Article | Year |
---|---|
Naturally occurring phenethyl isothiocyanate-induced inhibition of gastric cancer cell growth by disruption of microtubules.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Transformation, Neoplastic; Glutathione; Humans; Isothiocyanates; Microtubules; Phytotherapy; Stomach Neoplasms | 2014 |
Inhibitory effect of phenethyl isothiocyanate against benzo[a] pyrene-induced rise in CYP1A1 mRNA and apoprotein levels as its chemopreventive properties.
Topics: Animals; Anticarcinogenic Agents; Apoproteins; Benzo(a)pyrene; Cell Transformation, Neoplastic; Chemoprevention; Cytochrome P-450 CYP1A1; Isothiocyanates; Liver; Male; Polycyclic Aromatic Hydrocarbons; Rats; Rats, Wistar; RNA, Messenger | 2015 |
Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination.
Topics: Animals; Antineoplastic Agents; Carcinogenicity Tests; Cell Transformation, Neoplastic; Cysteine; Disease Models, Animal; Female; Inositol; Isothiocyanates; Lung Neoplasms; Mice; Thiocarbamates | 2002 |
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.
Topics: Animals; Antioxidants; Cell Death; Cell Line; Cell Transformation, Neoplastic; Fusion Proteins, bcr-abl; Glutathione; Humans; Isothiocyanates; Mice; Neoplasms; Oncogene Protein p21(ras); Reactive Oxygen Species; Survival Rate; Xenograft Model Antitumor Assays | 2006 |
Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Ascorbic Acid; Carcinogens; Cell Transformation, Neoplastic; Chemoprevention; Diet; Female; Hydroquinones; Isothiocyanates; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1998 |
In vitro induction of benzo(a)pyrene cell-transforming activity by the glucosinolate gluconasturtiin found in cruciferous vegetables.
Topics: 3T3 Cells; Aldehyde Dehydrogenase; Animals; Benzo(a)pyrene; Brassica; Carcinogens; Cell Survival; Cell Transformation, Neoplastic; Cocarcinogenesis; Drug Synergism; Glucosinolates; Glycoside Hydrolases; In Vitro Techniques; Isothiocyanates; Mice; Mice, Inbred BALB C; Risk Factors | 2002 |